Clinical Trial Update: A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial assessing cannabidiol as add-on therapy for refractory epilepsy; efficacy and safety results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Antonio Waldo Zuardi | Conditions: Epilepsy | Phase 3 | Status: UNKNOWN